Merus N.V.
Company Information
Industry Pharmaceutical Preparations
SIC Code 2834
Entity Type operating
SEC Category Large accelerated filer
State of Incorporation Netherlands
Business Address YALELAAN 62, 3584 CM UTRECHT, DE,
Mailing Address YALELAAN 62, 3584 CM UTRECHT, DE,
Phone 31 030 253 8800
Fiscal Year End 1231
EIN 000000000
Financial Overview
FY2024
$782.69M
Total Assets
$134.77M
Total Liabilities
$647.93M
Stockholders' Equity
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13D/A Beneficial ownership amendment | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 30, 2025 | View on SEC |
| 8-K Current report of material events | December 30, 2025 | View on SEC |
| 4 Insider stock transaction report | December 29, 2025 | View on SEC |
| 4 Insider stock transaction report | December 22, 2025 | View on SEC |
| SCHEDULE 13D Beneficial ownership report (>5%) | December 19, 2025 | View on SEC |
| 4 Insider stock transaction report | December 18, 2025 | View on SEC |
| 3 Initial insider ownership report | December 18, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
| 4 Insider stock transaction report | December 12, 2025 | View on SEC |
Material Events
8-K Acquisition December 30, 2025
High Impact
- Merus N.V. has been acquired by Genmab A/S through its subsidiary.
- Genmab bought almost all of Merus's common shares for $97.00 each in cash.
8-K Acquisition December 12, 2025
High Impact
- Merus N.V. has been acquired by Genmab A/S through one of its subsidiaries.
- Genmab purchased almost all of Merus's shares for $97.00 per share in cash.
8-K Acquisition December 9, 2025
High Impact
- Merus N.V. shareholders approved proposals related to the company's acquisition by Genmab A/S.
- Genmab A/S is acquiring all of Merus's outstanding shares for $97.00 per share in cash.
Insider Trading
STRONG BUY 2 insiders
13 recent transactions
View Full Insider Trading Profile
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.